230. 肺胞低換気症候群 Alveolar hypoventilation syndrome Clinical trials / Disease details

臨床試験数 : 6 / 薬物数 : 7 - (DrugBank : 4) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 26

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01500473 (ClinicalTrials.gov)	February 2012	22/12/2011	Therapeutic Effect of Desogestrelon Ventilatory Control in Patients With Congenital Central Hypovent ...	Therapeutic Effect of Desogestrelon Ventilatory Control in Patients With Congenital Central Hypovent ...	Congenital Central Hypoventilation Syndrome	Drug: Desogestrel	Children's Hospital Los Angeles	NULL	Not yet recruiting	16 Years	50 Years	Female	8	N/A	United States
2	NCT01243697 (ClinicalTrials.gov)	April 2011	17/11/2010	Assessment of Desogestrel in Ondine Syndrome	Assessment of Desogestrelfor a Pharmacological Recovery of Ventilatory Activity in Congenital Centra ...	Ondine Syndrome	Drug: desogestrel	Assistance Publique - Hôpitaux de Paris	NULL	Completed	10 Years	60 Years	Female	6	Phase 2/Phase 3	France
3	EUCTR2011-000989-35-FR (EUCTR)		06/05/2011	N/A	N/A - RESPIRONDINE	MedDRA version: 14.0;Level: PT;Classification code 10066131;Term: Congenital central hypoventilatio ...	Trade Name: Cerazette Product Name: Cerazette INN or Proposed INN: Désogestrel	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	NA			Female: yes Male: no		Phase 2	France

First Previous1Next Last